Ascentage Pharma Announces Partial Exercise of Underwriters’ Option to Purchase Additional American Depositary Shares

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

ROCKVILLE, Md. and SUZHOU, China, Feb. 07, 2025 (GLOBE NEWSWIRE) — Ascentage Pharma (Nasdaq: AAPG, HKEX: 6855) announced today that the underwriters of its underwritten U.S. initial public offering (the “Offering”) have partially exercised their over-allotment option to purchase an additional 935,144 American depositary shares (“ADSs”) at the initial public offering price of $17.25 per ADS less underwriting discounts and commissions. Each ADS represents four ordinary shares of Ascentage Pharma. After giving effect to the partial exercise of the over-allotment option, the total number of ADSs sold by Ascentage Pharma in the Offering will increase to 8,260,144 ADSs and the aggregate gross proceeds to Ascentage Pharma will be approximately $142.5 million, before deducting underwriting discounts and commissions and other offering expenses payable by Ascentage Pharma. The closing of the over-allotment option is subject to customary closing conditions.

J.P. Morgan and Citigroup acted as joint book-running managers for the offering.

About Ascentage Pharma

Ascentage Pharma is a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in hematological malignancies. Ascentage Pharma has been listed on the Main Board of the Stock Exchange of Hong Kong Limited with the stock code 6855.HK since October 2019 and has also been listed on the Nasdaq Global Market under the ticker symbol “AAPG” since January 2025.

Contacts

Investor Relations

Hogan Wan, Head of IR and Strategy
Ascentage Pharma
Hogan.Wan@ascentage.com
+86 512 85557777

Stephanie Carrington
ICR Healthcare
Stephanie.Carrington@icrhealthcare.com
(646) 277-1282 

Media Relations

Sean Leous
ICR Healthcare
Sean.Leous@icrhealthcare.com
(646) 866-4012

Staff

Recent Posts

Healing Realty Trust Appoints Healthcare Staffing Veteran Matt Young to Board of Directors

Jupiter, Florida--(Newsfile Corp. - June 11, 2025) - Healing Realty Trust, a data-driven, self-managed real…

2 hours ago

YOUR SKIN BARRIER NEEDS YOU: BYOMA LAUNCHES SECOND ANNUAL SKIN BARRIER AWARENESS MONTH

BYOMA, the trailblazing brand investing millions to improve worldwide skin barrier health, announces the second…

2 hours ago

South Dakota Office of Licensing and Accreditation (OLA) Implements New MIS from RedMane Technology

CHICAGO, June 11, 2025 /PRNewswire/ -- South Dakota Office of Licensing and Accreditation (OLA) recently…

2 hours ago

Zorro Secures $20 Million in Series A to Transform the Healthcare Benefits Industry for Brokers, Employers and Employees

First-of-its-Kind Insurtech Bridges Gap between Health and Financial Wellbeing, Offering a Benefits Solution that Delivers…

2 hours ago